×
0 0 0 0 0 0 0 0
Stockreport

Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2017 

AKCEA THERAPEUTICS (AKCA)  More Company Research Source: GlobeNewswire
Last akcea therapeutics earnings: 8/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.akceatx.com/media-investors/press-releases
PDF Preparing for mid-2018 approval and launch of volanesorsen for FCS in the US, EU and Canada Advancing the pipeline with four Phase 2 trials underway and data planned from two studies in 2018 Conference Call Webcast Monday, February 26, 4:30 p.m. ET at www.akceatx.com CAMBRIDGE, Mass., Feb. 26, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., today reported financial results for the fourth quarter and year ended December 31, 2017. Akcea is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases. The company reported an operating loss for the fourth quarter and year ended December 31, 2017 on a GAAP basis of $25 million and $109 million, respectively, and on a pro forma basis of $19 million and $91 million, respectively. Akcea had $260 million of cash, cash equivalents and short-term investments as of December 31, 2017. “With our marketing submissions accepted in the US, EU [Read more]

IMPACT SNAPSHOT EVENT TIME: AKCA
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS